Analyst Ratings for Recursion Pharmaceuticals (RXRX)
RXRX Rating Summary
RXRX Price Target Summary
- Highest: $35.00 (Berenberg)
- Lowest: $10.00 (JPMorgan)
- Average: $17.60
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$17.60 (+73.1%)
* Over Last 12-Mos
Rating Score: 3.3 / 10 Percentile Rank: 30%
Rating Score: 3.3 / 10 Percentile Rank: 30%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
1/26/2024 | TD Cowen | Steven Mah | New Coverage | Hold (N/A) |
N/A (N/A) |
10.23 (10.17) |
-0.59% | Details |
5/22/2023 | Morgan Stanley » Updated 7/13/2023 |
Vikram Purohit | New Coverage | Equalweight (N/A) |
11.00 (8.00) |
5.47 (10.17) |
85.92% | Details |